Impact of sex hormones on sarcopenia and osteoporosis in geriatric patients

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00033258

Enrollment

600

Registered

2023-12-15

Start date

2022-05-05

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

M62.5

Interventions

Group 1: The project is a retrospective cross-sectional study. The primary aim is to analyze the prevalence of sex hormone deficiency in geriatric patients. If the prevalence is sufficient, the patien

Eligibility

Sex/Gender

All

Age

65 Years to No maximum

Inclusion criteria

Inclusion criteria: Inpatient treatment in acute geriatrics during the period from January 1, 2018, to October 31, 2021 and performed hormone analysis

Exclusion criteria

Exclusion criteria: Incorrectly performed bone density measurement using DXA

Design outcomes

Primary

Measure	Time frame
muscle mass	—

Secondary

Measure	Time frame
muscle function (handgrip strength)	—

Countries

Germany

Contacts

Public ContactSabine Schlüssel

Medizinische Klinik und Poliklinik IV LMU

Sabine.Schluessel@med.uni-muenchen.de089 4400 55424

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026